# Oxytocin Treatment of Opioid Dependence

> **NCT02548728** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 12 (actual)

## Conditions studied

- Opioid Dependence
- Opioid Withdrawal

## Interventions

- **DRUG:** Intranasal Oxytocin Spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02548728
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02548728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02548728, "Oxytocin Treatment of Opioid Dependence". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT02548728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*